SK3442003A3 - Phenoxyphenyl alkane sulfonates, method for producing thereof, their use in production of medicaments that comprise said compounds - Google Patents

Phenoxyphenyl alkane sulfonates, method for producing thereof, their use in production of medicaments that comprise said compounds Download PDF

Info

Publication number
SK3442003A3
SK3442003A3 SK344-2003A SK3442003A SK3442003A3 SK 3442003 A3 SK3442003 A3 SK 3442003A3 SK 3442003 A SK3442003 A SK 3442003A SK 3442003 A3 SK3442003 A3 SK 3442003A3
Authority
SK
Slovakia
Prior art keywords
compounds
phenoxyphenyl
formula
trifluoromethyl
group
Prior art date
Application number
SK344-2003A
Other languages
English (en)
Slovak (sk)
Inventor
Markus Heil
Heinrich Meier
Paul Naab
Arnd Voerste
Vry Jean-Marie-Viktor De
Dirk Denzer
Frank Mauler
Klemens Lustig
Jan-Bernd Lenfers
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Ag filed Critical Bayer Ag
Publication of SK3442003A3 publication Critical patent/SK3442003A3/sk

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C309/00—Sulfonic acids; Halides, esters, or anhydrides thereof
    • C07C309/63—Esters of sulfonic acids
    • C07C309/64—Esters of sulfonic acids having sulfur atoms of esterified sulfo groups bound to acyclic carbon atoms
    • C07C309/65—Esters of sulfonic acids having sulfur atoms of esterified sulfo groups bound to acyclic carbon atoms of a saturated carbon skeleton
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C309/00—Sulfonic acids; Halides, esters, or anhydrides thereof
    • C07C309/01—Sulfonic acids
    • C07C309/02—Sulfonic acids having sulfo groups bound to acyclic carbon atoms
    • C07C309/20—Sulfonic acids having sulfo groups bound to acyclic carbon atoms of an acyclic unsaturated carbon skeleton
    • C07C309/22—Sulfonic acids having sulfo groups bound to acyclic carbon atoms of an acyclic unsaturated carbon skeleton containing carboxyl groups bound to the carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/01—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms
    • C07C311/02—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton
    • C07C311/08—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton having the nitrogen atom of at least one of the sulfonamide groups bound to a carbon atom of a six-membered aromatic ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/01—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms
    • C07C311/02—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton
    • C07C311/09—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton the carbon skeleton being further substituted by at least two halogen atoms

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Pain & Pain Management (AREA)
  • Hospice & Palliative Care (AREA)
  • Pulmonology (AREA)
  • Psychiatry (AREA)
  • Ophthalmology & Optometry (AREA)
  • Immunology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Rheumatology (AREA)
  • Anesthesiology (AREA)
  • Psychology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Nutrition Science (AREA)
  • Otolaryngology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
SK344-2003A 2000-09-26 2001-09-13 Phenoxyphenyl alkane sulfonates, method for producing thereof, their use in production of medicaments that comprise said compounds SK3442003A3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10047486A DE10047486A1 (de) 2000-09-26 2000-09-26 Phenoxyphenyl Alkansulfonate
PCT/EP2001/010564 WO2002026702A1 (fr) 2000-09-26 2001-09-13 Sulfonates d'alcane de phenoxyphenyle

Publications (1)

Publication Number Publication Date
SK3442003A3 true SK3442003A3 (en) 2003-10-07

Family

ID=7657564

Family Applications (1)

Application Number Title Priority Date Filing Date
SK344-2003A SK3442003A3 (en) 2000-09-26 2001-09-13 Phenoxyphenyl alkane sulfonates, method for producing thereof, their use in production of medicaments that comprise said compounds

Country Status (34)

Country Link
US (2) US6756409B2 (fr)
EP (1) EP1334086B1 (fr)
JP (1) JP2004509946A (fr)
KR (1) KR20030039372A (fr)
CN (1) CN1476427A (fr)
AR (1) AR033575A1 (fr)
AT (1) ATE292621T1 (fr)
AU (2) AU2054702A (fr)
BG (1) BG107634A (fr)
BR (1) BR0114182A (fr)
CA (1) CA2423171A1 (fr)
DE (2) DE10047486A1 (fr)
EE (1) EE200300117A (fr)
ES (1) ES2240543T3 (fr)
GT (1) GT200100193A (fr)
HN (1) HN2001000214A (fr)
HR (1) HRP20030326A2 (fr)
HU (1) HUP0302258A3 (fr)
IL (1) IL154968A0 (fr)
MA (1) MA26053A1 (fr)
MX (1) MXPA03002546A (fr)
NO (1) NO20031357L (fr)
NZ (1) NZ524886A (fr)
PE (1) PE20020408A1 (fr)
PL (1) PL361015A1 (fr)
PT (1) PT1334086E (fr)
RU (1) RU2278853C2 (fr)
SI (1) SI1334086T1 (fr)
SK (1) SK3442003A3 (fr)
SV (1) SV2002000639A (fr)
UA (1) UA75369C2 (fr)
UY (1) UY26945A1 (fr)
WO (1) WO2002026702A1 (fr)
ZA (1) ZA200302275B (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003061699A1 (fr) * 2001-12-27 2003-07-31 Japan Tobacco, Inc. Remedes pour affections allergiques
US8772326B2 (en) 2008-07-10 2014-07-08 Anigion Biomedica Corp. Methods and compositions of small molecule modulators of hepatocyte growth factor (scatter factor) activity
US10709497B2 (en) * 2017-09-22 2020-07-14 Covidien Lp Electrosurgical tissue sealing device with non-stick coating
SG11202110406SA (en) 2019-04-11 2021-10-28 Angion Biomedica Corp Solid forms of (e)-3-[2-(2-thienyl)vinyl]-1h-pyrazole

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE216642C (fr) *
BE786644A (fr) * 1971-07-23 1973-01-24 Hoechst Ag Derives d'acides phenoxy-4 phenoxy-alcane-carboxyliques leur preparation et les medicaments qui en contiennent
US3914418A (en) * 1971-09-02 1975-10-21 Merck & Co Inc Methods of controlling liver fluke infections
GB8914660D0 (en) * 1989-06-26 1989-08-16 Fujisawa Pharmaceutical Co Aniline derivatives,processes for production thereof and pharmaceutical compositions comprising the same
MY117939A (en) * 1996-07-25 2004-08-30 Lg Chemical Ltd Composition for enhancing oral hygiene
US6090839A (en) * 1996-12-23 2000-07-18 Merck & Co., Inc. Antidiabetic agents
PT966436E (pt) * 1997-02-21 2003-03-31 Bayer Ag Arilsulfonamidas e analogos e sua aplicacao para o tratamento de doencas neurodegenerativas
US5925654A (en) * 1997-03-12 1999-07-20 G.D. Searle & Co. LTA4 , hydrolase inhibitors
ATE231487T1 (de) * 1997-10-20 2003-02-15 Taisho Pharmaceutical Co Ltd 2-phenoxyanilin-derivate
US6231875B1 (en) * 1998-03-31 2001-05-15 Johnson & Johnson Consumer Companies, Inc. Acidified composition for topical treatment of nail and skin conditions
NL1008795C2 (nl) * 1998-04-02 1999-10-05 Rene Werenfridus Lodewijk Vroo Samenstelling voor het behandelen van hoeven en werkwijze voor het vervaardigen van de samenstelling.
HN1998000027A (es) * 1998-08-19 1999-06-02 Bayer Ip Gmbh Arilsulfonamidas y analagos
DE19837627A1 (de) * 1998-08-19 2000-02-24 Bayer Ag Neue Aminosäureester von Arylsulfonamiden und Analoga
US6242422B1 (en) * 1998-10-22 2001-06-05 Idun Pharmacueticals, Inc. (Substituted)Acyl dipeptidyl inhibitors of the ice/ced-3 family of cysteine proteases

Also Published As

Publication number Publication date
MA26053A1 (fr) 2004-04-01
IL154968A0 (en) 2003-10-31
SI1334086T1 (en) 2005-10-31
UA75369C2 (en) 2006-04-17
WO2002026702A1 (fr) 2002-04-04
CA2423171A1 (fr) 2003-03-21
KR20030039372A (ko) 2003-05-17
MXPA03002546A (es) 2004-04-20
NZ524886A (en) 2005-09-30
US6756409B2 (en) 2004-06-29
AU2054702A (en) 2002-04-08
AR033575A1 (es) 2003-12-26
BG107634A (bg) 2003-12-31
ES2240543T3 (es) 2005-10-16
HN2001000214A (es) 2001-10-25
EE200300117A (et) 2005-04-15
NO20031357D0 (no) 2003-03-25
JP2004509946A (ja) 2004-04-02
UY26945A1 (es) 2002-04-26
CN1476427A (zh) 2004-02-18
US20030022934A1 (en) 2003-01-30
PL361015A1 (en) 2004-09-20
PE20020408A1 (es) 2002-06-08
NO20031357L (no) 2003-03-25
US20040214886A1 (en) 2004-10-28
HRP20030326A2 (en) 2005-02-28
HUP0302258A3 (en) 2006-02-28
DE50105857D1 (de) 2005-05-12
ZA200302275B (en) 2004-03-24
PT1334086E (pt) 2005-08-31
AU2002220547B2 (en) 2006-11-02
EP1334086A1 (fr) 2003-08-13
RU2278853C2 (ru) 2006-06-27
EP1334086B1 (fr) 2005-04-06
GT200100193A (es) 2002-06-04
HUP0302258A2 (hu) 2003-11-28
SV2002000639A (es) 2002-10-24
ATE292621T1 (de) 2005-04-15
BR0114182A (pt) 2003-07-29
DE10047486A1 (de) 2002-04-11

Similar Documents

Publication Publication Date Title
US6037362A (en) Tricyclic compounds and drug compositions containing the same
KR100586349B1 (ko) 아릴술폰아미드 및 그의 유사체, 및 신경 변성 질병 치료에있어서 그의 용도
JP4664814B2 (ja) イミダゾリジン誘導体
JP2023539194A (ja) Ａｐｏｌ１の阻害剤およびこれを使用する方法
JP2023017862A (ja) 疾患の処置のための複素環化合物
PL185875B1 (pl) Trójpodstawione pochodne fenylowe i kompozycja farTrójpodstawione pochodne fenylowe i kompozycja farmaceutyczna zawierająca trójpodstawione pochodne fmaceutyczna zawierająca trójpodstawione pochodne fenyloweenylowe
SK3442003A3 (en) Phenoxyphenyl alkane sulfonates, method for producing thereof, their use in production of medicaments that comprise said compounds
IL297974A (en) History of 4-(6,2-difluorophenoxy)-6-(trifluoromethyl)pyrimidine-2-amine as a sensitizer of th hmrgx1 receptor for pain treatment
KR20000075493A (ko) 아릴술폰아미드 및 그의 동족체, 및 신경 변성 질병 치료에 있어서 그의 용도
NZ717688A (en) Liver x receptor (lxr) modulators
EP1254106B1 (fr) Composes calcilytiques
US20030232802A1 (en) Aryl and heteroaryl sulfonates
US20040014723A1 (en) Calcilytic compounds
DE60209029T2 (de) Polycyclische verbindungen mit antitumor-wirkung
US20080114005A1 (en) Fibrate Compounds Having Ppar Agonist Activity
AU2016399299B2 (en) Crystalline form
JPH08134030A (ja) ベンゾシクロアルケン類、その製造法および剤
WO2009117278A2 (fr) Procédés de préparation d'éthers de biaryle substitués par un (amino-pyrazolopyridinyl)méthoxy

Legal Events

Date Code Title Description
FB9A Suspension of patent application procedure